National Research Corp. (NASDAQ:NRCIA) was downgraded by Zacks Investment Research from a “strong-buy” rating to a “hold” rating in a report released on Wednesday.

According to Zacks, “National Research Corporation offers analytics and insights that facilitate revenue growth, patient, employee, customer retention and patient engagement for healthcare providers, payers and other healthcare organizations. Its services include capture, interpretation, transmittal and benchmarking of critical data elements from various healthcare consumers. National Research Corporation is headquartered in Lincoln, Nebraska. “

Separately, TheStreet raised shares of National Research Corp. from a “hold” rating to a “buy” rating in a research note on Wednesday, August 10th.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

Shares of National Research Corp. (NASDAQ:NRCIA) traded up 0.38% during trading on Wednesday, reaching $15.69. 5,678 shares of the company were exchanged. The company has a 50 day moving average price of $16.03 and a 200-day moving average price of $14.93. The stock has a market capitalization of $380.03 million, a price-to-earnings ratio of 19.28 and a beta of 1.69. National Research Corp. has a one year low of $12.53 and a one year high of $17.42.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 14th. Stockholders of record on Friday, September 30th will be issued a $0.08 dividend. This represents a $0.32 annualized dividend and a dividend yield of 2.04%. The ex-dividend date of this dividend is Wednesday, September 28th. National Research Corp.’s payout ratio is presently 68.09%.

5 Day Chart for NASDAQ:NRCIA

Get a free copy of the Zacks research report on National Research Corp. (NRCIA)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for National Research Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corp. and related companies with's FREE daily email newsletter.